echo ''; Clamorworld » In everyday life every one of us comes across various experiences, incidents which we either don’t share with anyone or share with family members and friends. Print media, electronic media and various medium shows the news, but its ends up showing one sided of the story. We never come to know the other side of story. With so much happening every day, every second across our neighborhood, society, and world it’s difficult for the news media to cover all the news. Many times we have felt wish we could share our voice, opinion, thoughts with the world. Many a times we have felt the frustration, anger and helplessness for not being able to do anything about an incident. Have you ever felt, for a good cause, you need support, but don’t know how to garner the support and attention. So, now you have an option ““. This is a platform to share everything you want to. A website 100% runs by the people for the people. The world is waiting to listen to your voice, the voice which has kept you suppressed so far. If you do not want to share the incident, event personally, please send it to us at, and we will share it on your behalf and assure to keep your name confidential. Let’s make this world a peaceful and a happy place to live. » Avocados may help beat leukemia

Avocados may help beat leukemia



Adding to the benefits of avocados, scientists have found that the nutritious fruit may hold the key to beating deadly leukemia.

University of Waterloo Professor Paul Spagnuolo has discovered a lipid in avocados that combats acute myeloid leukemia (AML) by targeting the root of the disease – leukemia stem cells. Worldwide, there are few drug treatments available to patients that target leukemia stem cells.

AML is a devastating disease and proves fatal within five years for 90% of seniors over age 65.

Spagnuolo said that the stem cell is largely responsible for the disease developing and it’s the reason why so many patients with leukemia relapse. He and his team performed many rounds of testing to determine how the new drug worked at a molecular level and confirmed that it targets stem cells selectively, leaving healthy cells unharmed.

He added that not only does avocatin B eliminate the source of AML, but its targeted, selective effects make it less toxic to the body, too.

The drug is still years away from becoming approved for use in oncology clinics, but Spagnuolo is already performing experiments to prepare the drug for a Phase I clinical trial.

Spagnuolo is among only a handful of researchers worldwide, applying the pharmaceutical industry’s rigorous drug discovery research processes to food-derived compounds, called nutraceuticals.

The research is published in the journal Cancer Research.

Leave a reply